UVB‐generated Microvesicle Particles: A Novel Pathway by Which a Skin‐specific Stimulus Could Exert Systemic Effects

Ultraviolet B radiation (UVB) exerts profound effects on human skin. Much is known regarding the ability of UVB to generate a plethora of bioactive agents ranging from cytokines and other bioactive proteins, lipid mediators and microRNAs. It is presumed that these agents are in large part responsible for the effects of UVB, which is only absorbed appreciably in the epidermis. However, the exact mechanism by which these bioactive agents can leave the epidermis are as yet unclear. This review addresses the potential role of microvesicle particles (MVP) as UVB signaling agents through transmitting biologic mediators. New data are provided that UVB treatment of human skin explants also generates MVP production. We hypothesize that UVB production of MVPs (UVB‐MVP) could serve this important function of transmitting keratinocyte‐derived bioactive agents. Moreover, we propose that UVB‐MVP formation involves the lipid mediator platelet‐activating factor. This novel pathway has the potential to be exploited pharmacologically to modulate UVB effects.

[1]  S. Ullrich,et al.  Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer. , 2016, Progress in lipid research.

[2]  M. Takata,et al.  Alveolar macrophage-derived microvesicles mediate acute lung injury , 2016, Thorax.

[3]  J. Travers,et al.  UVB Generates Microvesicle Particle Release in Part Due to Platelet‐activating Factor Signaling , 2016, Photochemistry and photobiology.

[4]  C. Thompson,et al.  Microparticles generated during chronic cerebral ischemia increase the permeability of microvascular endothelial barriers in vitro , 2016, Brain Research.

[5]  Jinju Wang,et al.  Cellular Membrane Microparticles: Potential Targets of Combinational Therapy for Vascular Disease. , 2015, Current vascular pharmacology.

[6]  R. Gallo,et al.  Innate immune sensors stimulate inflammatory and immunosuppressive responses to UVB radiation. , 2014, The Journal of investigative dermatology.

[7]  A. Tedgui,et al.  Microvesicles as Cell–Cell Messengers in Cardiovascular Diseases , 2014, Circulation research.

[8]  Ying Ma,et al.  An essential role for platelet‐activating factor in activating mast cell migration following ultraviolet irradiation , 2014, Journal of leukocyte biology.

[9]  Michael J. Atkinson,et al.  UVA and UVB Irradiation Differentially Regulate microRNA Expression in Human Primary Keratinocytes , 2013, PloS one.

[10]  Shuzhen Chen,et al.  Effects of Endothelial Progenitor Cell-Derived Microvesicles on Hypoxia/Reoxygenation-Induced Endothelial Dysfunction and Apoptosis , 2013, Oxidative medicine and cellular longevity.

[11]  T. Oberyszyn,et al.  Ultraviolet light exposure stimulates HMGB1 release by keratinocytes , 2013, Archives of Dermatological Research.

[12]  S. Jarrett,et al.  UV Radiation and the Skin , 2013, International journal of molecular sciences.

[13]  G. Chironi,et al.  Shear Stress Regulates Endothelial Microparticle Release , 2013, Circulation research.

[14]  D. Tregouet,et al.  Small platelet microparticle levels are increased in pulmonary arterial hypertension , 2013, European journal of clinical investigation.

[15]  D. Pisetsky,et al.  Microparticles as mediators and biomarkers of rheumatic disease. , 2012, Rheumatology.

[16]  R. Cerione,et al.  R(h)oads to microvesicles , 2012, Small GTPases.

[17]  J. Travers,et al.  Platelet-activating Factor Receptor Agonists Mediate Xeroderma Pigmentosum A Photosensitivity* , 2012, The Journal of Biological Chemistry.

[18]  F. Aubin,et al.  Increased levels of circulating endothelial-derived microparticles and small-size platelet-derived microparticles in psoriasis. , 2011, The Journal of investigative dermatology.

[19]  Cheng Zhang,et al.  Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage. , 2011, American journal of physiology. Endocrinology and metabolism.

[20]  Christian Weber,et al.  Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange , 2010, Circulation research.

[21]  Ming-Lin Liu,et al.  Tobacco Smoke Induces the Generation of Procoagulant Microvesicles From Human Monocytes/Macrophages , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Qiaofang Yi,et al.  Ultraviolet B Radiation of Human Skin Generates Platelet‐activating Factor Receptor Agonists , 2010, Photochemistry and photobiology.

[23]  Graca Raposo,et al.  ARF6-Regulated Shedding of Tumor Cell-Derived Plasma Membrane Microvesicles , 2009, Current Biology.

[24]  Winfried Schuller,et al.  UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. , 2009, The Journal of allergy and clinical immunology.

[25]  D. Stafforini.  Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2) , 2009, Cardiovascular Drugs and Therapy.

[26]  W. Grossman,et al.  Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. , 2008, American journal of respiratory and critical care medicine.

[27]  H. Edenberg,et al.  Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor. , 2008, The Journal of investigative dermatology.

[28]  M. Garmyn,et al.  The Molecular and Genetic Effects of Ultraviolet Radiation Exposure on Skin Cells , 2007 .

[29]  J. Travers,et al.  Ultraviolet B Radiation Generates Platelet-activating Factor-like Phospholipids underlying Cutaneous Damage* , 2005, Journal of Biological Chemistry.

[30]  N. Cox.  Fitzpatrick's Dermatology in General Medicine. , 2004 .

[31]  R. Nieuwland,et al.  Microparticles in cardiovascular diseases. , 2003, Cardiovascular research.

[32]  J. Travers,et al.  The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. , 2002, Journal of Pharmacology and Experimental Therapeutics.

[33]  S. Ullrich,et al.  Platelet-activating Factor, a Molecular Sensor for Cellular Damage, Activates Systemic Immune Suppression , 2002, The Journal of experimental medicine.

[34]  F. Di Virgilio,et al.  Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. , 1999, Journal of cell science.

[35]  D. Williams,et al.  Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. , 1998, Journal of immunology.

[36]  D. Williams,et al.  Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseases. , 1998, Prostaglandins & other lipid mediators.

[37]  D. Handley.  Preclinical and clinical pharmacology of platelet‐activating factor receptor antagonists , 1990, Medicinal research reviews.

[38]  T. Luger,et al.  Fever and increased serum IL-1 activity as a systemic manifestation of acute phototoxicity in New Zealand White rabbits. , 1987, The Journal of investigative dermatology.